In Vivo Expansion of Activated Foxp3 + Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis

Jérôme Biton (1, 2, 3) , Sara Khaleghparast Athari (3, 2) , Allan Thiolat (3) , François Santinon , Delphine Lemeiter (4) , Roxane Hervé (3) , Laure Delavallée (5) , Anaïs Levescot (6) , Stéphane Roga (7) , Patrice P. Decker (8) , Jean-Philippe Girard (7) , André Herbelin (6) , Marie-Christophe Boissier (8) , Natacha Bessis (5)

1 UP13 - Université Paris 13
2 USPC - Université Sorbonne Paris Cité
3 Physiopathologie et Biotherapies de la Polyarthrite Rhumatoide
4 EA4222, Li2P
5 EA-4222 - UPRES
6 IRTOMIT [Poitiers] - Ischémie Reperfusion en Transplantation d’Organes Mécanismes et Innovations Thérapeutiques [U 1082]
7 IPBS - Institut de pharmacologie et de biologie structurale
8 Li2P - Physiopathologie, cibles et thérapies de la polyarthrite rhumatoïde

Domaines: Sciences du Vivant [q-bio]; Médecine humaine et pathologie

Jérôme Biton, Sara Khaleghparast Athari, Allan Thiolat, François Santinon, Delphine Lemeiter, et al.. In Vivo Expansion of Activated Foxp3 + Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis. Journal of Immunology, 2016, 197 (5), pp.1708 - 1719. ⟨10.4049/jimmunol.1502124⟩. ⟨hal-01933351⟩